Brochure
29 Nov 2023
Lyrus Life Science Brochure
PDF 1.0 MB
Introduction:The Lyrus Life Science brochure provides a comprehensive overview of our company's capabilities, management profile, research and development strengths, and production facilities. It serves as a valuable resource to gain insights into our operations and the therapies we specialize in. At Lyrus Life Science, we are committed to developing innovative products using non-infringing technologies, revolutionizing the healthcare industry.
Content provided by our supplier
Lyrus Life Sciences
-
Country/Region:India
-
On CPHI since:2019
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
Other Content from Lyrus Life Sciences (2)
-
News MHRA approvals
MA received from MHRA for Mebeverine, Procyclidine, Nitrofurantoin Susp, Metformin XR, Metformin IR, Para Codeine tabs, Trazodone Caps, Mefenamic Acid Caps 250mg, Lymecycline Caps 408mg, Lisinopril Oral solution, -
News Lyrus Receives US FDA approval for Critical UTI treatment in the US
Lyrus has received US FDA approval for our Abbreviated New Drug Application (ANDA) for 'Methenamine Hippurate Tablets USP, 1 gram', an AB-rated, substitutable generic version of Hiprex®.